• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Younger America's Wholly-Owned Subsidiary, Life Without Pain, Has Sold 3,715 MEDLIGHT(TM) 630PRO Devices on Home Shopping Network

Posted on: Thursday, 14 June 2007, 09:27 CDT

Younger America (Pink Sheets:YNGR) is pleased to announce that the Company's wholly-owned subsidiary, Life Without Pain, has sold 3,715 MEDLIGHT™ 630PRO devices on the Home Shopping Network. The units were sold for $189 plus shipping and handling per device.

Currently, the Home Shopping Network has a purchase order for 7,175 MEDLIGHT™ 630PRO devices that are still available on its Web site.

Based on the NASA-developed LED technology, the MEDLIGHT™ 630PRO offers Life Without Pain's patented 81 LED array in a lightweight and easy-to-use AC-powered device. The MEDLIGHT™ 630PRO offers powerful affordable pain relief and will not damage any tissue. The device is Food and Drug Administration cleared, Underwriters Laboratories approved, and CE approved. The CE mark is a mandatory European marking for certain product groups to indicate conformity with the essential health and safety requirements set out in European Directives, and allows Life Without Pain to sell the devices in the European Union.

"We are very pleased with the sales of our MEDLIGHT™ 630PRO and the branding of the products. The sales from the Home Shopping Network have proven to us that there is a huge interest in temporary pain relief without the use of potentially harmful drugs," stated Irwin Newman, President and Chairman of Younger America.

To purchase the MEDLIGHT™ 630PRO from the Home Shopping Network Web site, please visit: http://www.hsn.com/cnt/prod/default.aspx?webp_id=3241787&web_id=324178 7&ocm=sekw (Due to its length, this URL may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.)

About Younger America:

Younger America is a holding Company that develops and acquires under-valued companies that provide products to improve the quality of life without the use of potentially harmful drugs or chemicals. The Company aims to acquire a portfolio of companies that provide leading-edge alternative medical devices, systems and services. The roll-up of these companies will create value for the shareholders and provide innovative technologies and products that can enhance the quality of life for their customers.

Forward-Looking Statements:

Please be advised that statements made herein, other than historical data, constitute forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those stated or implied by such forward-looking statements. The potential risks and uncertainties include, among others, potential volatility in the Company's stock price, increased competition, customer acceptance of new products and services offered by the Company, and uncertainty of future revenue and profitability and fluctuations in its quarterly operating results. Please also be advised that the Company's stock is not currently registered with the Securities and Exchange Commission.

To automatically receive instant updates, press releases, and other information on this and other Big Apple Consulting USA companies, please visit http://www.bigappleconsulting.com/compro.php and download your FREE copy of Big Apple ComPro.

Source: Business Wire

More News in this Category